Investing.com - Top Choice Medical Investment reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Top Choice Medical Investment announced earnings per share of ¥0.68 on revenue of ¥821.20. Analysts polled by Investing.com anticipated EPS of ¥0.95 on revenue of ¥1.08B.
Top Choice Medical Investment shares are up 50% from the beginning of the year, still down 51.94% from its 52 week high of ¥253.30 set on October 26, 2021.
Top Choice Medical Investment shares lost 3.79% in intra-day trade following the report.
Top Choice Medical Investment follows other major Healthcare sector earnings this month
Top Choice Medical Investment's report follows an earnings missed by Walvax BioTech on Tuesday, who reported EPS of ¥0.07 on revenue of ¥1.36B, compared to forecasts EPS of ¥0.18 on revenue of ¥1.55B.
Autek China had beat expectations on Saturday with third quarter EPS of ¥0.28 on revenue of ¥526.7M, compared to forecast for EPS of ¥0.2532 on revenue of ¥587.16M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar